Department of Pharmaceutical Chemistry

MHC class II as novel entry receptor of influenza A viruses, a QBI/Gladstone Online Seminar

Mon Dec 12, 2022
Speaker Silke Stertz
The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series presents Silke Stertz, PhD, an Associate Professor in the Institute of Medical Virology at the University of Zurich, Switzerland. Silke Stertz studied biology in Freiburg, Germany, where she stayed on to obtain her...

Giacomini, Krogan, Shoichet, and Manglik recognized among most influential scientists

Thu Dec 8, 2022
headshots

Clockwise from top left: Giacomini, Krogan, Manglik, and Shoichet

Four School of Pharmacy faculty members rank in the top 1 percent of researchers for their highly cited work

Genentech-UCSF School of Pharmacy Diversity Fellowship opens doors for PhD careers in industry

Wed Dec 7, 2022
Genentech headquarters

Fellows will conduct 8 weeks of research at Genentech as part of a year long program.

New program to sponsor two graduate students from underrepresented backgrounds annually

Interplay between LRRK2 kinase and Rab GTPases in Parkinson’s disease, a QBI/Rezo Seminar with Dario Alessi

Mon Nov 28, 2022
Speaker Dario Alessi
QBI and Rezo Therapeutics present Dario Alessi, Director and Principal Investigator for the MRC Protein Phosphorylation and Ubiquitylation Unit at University of Dundee. Dario is a biochemist whose research focuses on unravelling the roles of poorly characterised components which regulate protein...

Structural studies towards the development of an oral protease inhibitor to treat SARS-CoV-2 infection, a QBI & Gladstone Online Seminar with Joanne Lemieux

Wed Nov 16, 2022
Lemieux
The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series presents Joanne Lemieux, Professor in the Department of Biochemistry and member of the Li Ka Shing Institute of Virology at the University of Alberta.

Lounge Ligands

Wed Nov 16, 2022
Digitally illustrated ligand lounging on a couch
John Walter
Lounge Ligands is a new art installation by QBI artist-in-residence John Walter, hosted by Professor Brian Shoichet. 

UCSF Quantitative Biosciences Institute and Institut Pasteur form center to fight infectious disease

Fri Oct 28, 2022
Krogan and Cole
© Institut Pasteur / François Gardy

QBI Director Nevan Krogan, PhD, and Professor Stewart Cole, PhD, president of the Institut Pasteur, sign the memorandum of understanding for the new Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases at a ceremony in the historic Musée Pasteur in Paris, France.

QBI Director Krogan receives the Legion of Honor, France’s highest award

A new era for science and practice at UCSF

Tue Oct 25, 2022
An aerial view of San Francisco
Brian Haux
Giacomini gathers a leadership team in pursuit of a new vision for the School of Pharmacy.

Team science in modern cancer immunology: embracing complexity thru collaboration, a QBI/SBI online seminar with Kimberly Luddy

Mon Oct 24, 2022
Speaker Kimberly Luddy on brown, yellow, and white celtic, geometric background
The QBI/SBI Seminar Series presents Kimberly Luddy, Senior Research Project Specialist in the Cancer Biology and Evolution Program at H. Lee Moffitt Cancer Center and Research Institute. Kimberly Luddy is an experimental and theoretical immunologist working at the interface of evolutionary biology...

Virtual drug screening leads to new compounds to treat pain and depression

Thu Oct 13, 2022
Shoichet
Elisabeth Fall

Brian Shoichet, PhD

Shoichet’s “docking” approach continues to produce better drugs with fewer side effects.

Pages